Spark Therapeutics Inc (272) is traded on Frankfurt Stock Exchange in Germany. and employs 27 people. The company currently falls under 'Mid-Cap
' category with current market capitalization of 2.1 B. Spark Therapeutics Inc has 31.22 M outstanding shares.
SPARK THERAPEUTICS has accumulated about 215.79 M in cash with (125.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.91.
Check Spark Therapeutics Probability Of Bankruptcy